The eSS rat, a nonobese model of disordered glucose and lipid metabolism and fatty liver.

Comparative study on the effects of type 1 and type 2 diabetes on structural changes and hormonal output of the adrenal cortex in male Wistar rats. J Diabetes Metab Disord (2013) 0.92

Long chain polyunsaturated fatty acids (LCPUFAs) and nordihydroguaiaretic acid (NDGA) modulate metabolic and inflammatory markers in a spontaneous type 2 diabetes mellitus model (Stillman Salgado rats). Lipids Health Dis (2016) 0.75

Pathogenesis of NIDDM. A balanced overview. Diabetes Care (1992) 6.56

Classification of hyperlipidaemias and hyperlipoproteinaemias. Bull World Health Organ (1970) 5.58

New insights into the regulation of HDL metabolism and reverse cholesterol transport. Circ Res (2005) 4.47

Regulation of plasma triglycerides in insulin resistance and diabetes. Arch Med Res (2005) 2.31

How good a marker is insulin level for insulin resistance? Am J Epidemiol (1993) 2.18

Overnight lowering of free fatty acids with Acipimox improves insulin resistance and glucose tolerance in obese diabetic and nondiabetic subjects. Diabetes (1999) 2.14

Hepatic very low density lipoprotein-ApoB overproduction is associated with attenuated hepatic insulin signaling and overexpression of protein-tyrosine phosphatase 1B in a fructose-fed hamster model of insulin resistance. J Biol Chem (2001) 1.50

Hepatic lipase, lipoprotein metabolism, and atherogenesis. Arterioscler Thromb Vasc Biol (2004) 1.49

Biochemical mechanism of lipid-induced impairment of glucose-stimulated insulin secretion and reversal with a malate analogue. J Biol Chem (2004) 1.43

Lipoprotein abnormalities and their consequences for patients with type 2 diabetes. Diabetes Obes Metab (2003) 1.42

Influence of hepatic steatosis (fatty liver) on severity and composition of dyslipidemia in type 2 diabetes. Diabetes Care (2006) 1.39

Alterations in high-density lipoprotein metabolism and reverse cholesterol transport in insulin resistance and type 2 diabetes mellitus: role of lipolytic enzymes, lecithin:cholesterol acyltransferase and lipid transfer proteins. Eur J Clin Invest (2003) 1.34

Insulin resistance: definition and consequences. Exp Clin Endocrinol Diabetes (2001) 1.25

Role of insulin resistance and lipotoxicity in non-alcoholic steatohepatitis. Clin Liver Dis (2009) 1.24

Fatty liver, insulin resistance, and dyslipidemia. Curr Diab Rep (2008) 1.17

Life and death decisions of the pancreatic beta-cell: the role of fatty acids. Clin Sci (Lond) (2007) 1.16

Saturated and unsaturated (including arachidonic acid) non-esterified fatty acid modulation of insulin secretion from pancreatic beta-cells. Biochem Soc Trans (2008) 1.16

Liver fat and lipid oxidation in humans. Liver Int (2009) 1.01

Non-esterified fatty acid concentrations are independently associated with hepatic steatosis in obese subjects. Diabetologia (2005) 0.99

Oral taurine but not N-acetylcysteine ameliorates NEFA-induced impairment in insulin sensitivity and beta cell function in obese and overweight, non-diabetic men. Diabetologia (2007) 0.98

Opposite contributions of trunk and leg fat mass with plasma lipase activities: the Hoorn study. Obes Res (2005) 0.95

The lipid profile and mortality risk in elderly type 2 diabetic patients: a ten-year follow-up study (ZODIAC-13). PLoS One (2009) 0.92

Hepatic lipase: friend or foe and under what circumstances? Curr Atheroscler Rep (2004) 0.88

Serum lipoprotein lipase mass: clinical significance of its measurement. Clin Chim Acta (2006) 0.85

Statins and diabetes. Semin Vasc Med (2004) 0.83

Hepatic delta9, delta6, and delta5 desaturations in non-insulin-dependent diabetes mellitus eSS rats. Lipids (2003) 0.82

The extended postprandial phase in diabetes. Biochem Soc Trans (2003) 0.81

Heritable, diet-induced hyperlipidemia in California mice (Peromyscus californicus) is due to increased hepatic secretion of very low density lipoprotein triacylglycerol. Comp Med (2006) 0.81

Expression of simian CETP in normolipidemic Fisher rats has a profound effect on large sized apoE-containing HDL. J Lipid Res (2002) 0.80

When HDL gets fat... Circ Res (2008) 0.79

[Dynamic modifications in islets of Langerhans in two lines of spontaneously diabetic rats]. Medicina (B Aires) (2007) 0.78

The metabolic syndrome in twins: a consequence of low birth weight or of being a twin? Exp Clin Endocrinol Diabetes (2001) 0.78

[Intermediate-density lipoproteins and liver lipase in postmenopausal women]. Medicina (B Aires) (1992) 0.78

Early lipid alterations in spontaneously diabetic rats. Acta Physiol Pharmacol Ther Latinoam (1998) 0.76